Thus, it was shown that MSA (3 mg/kg body weight) inhibited tumor growth up to 61% compared with the control group, and this inhibition was associated with a decrease in the level of plasma (TNFα)/interleukin 6 (IL6), and an increased level of GPXs in blood [83]. The gene discussed is IL6; the disease is neoplasm.